MTOR and ovarian carcinoma: Therefore, the molecular targeting of multiple signaling pathways such as EGFR, VEGFR, HIF-1, and PI3K/PTEN/AKT/mTOR may improve responses in recurrent and resistant ovarian cancers [4, 83, 92, 203, 205, 399–403].